Wednesday, April 16, 2014 7:34:24 PM
What I thought I stated was that, if the results of the Phase II studies become game changers, the CEO will change his game plan accordingly to optimize the potential, and will not allow the lack of capital to inhibit their growth. That does not make him disingenuous, it makes him a competent strategist.
Of course, if a capital raise is not necessary they will not do one. My point is, if they do one, it will be with very good reason and with long term benefit to the growth of the company.
I raised your hackles with my worthless and meaningless observations. As my point is apparently not understood, there is no point in further explanation or discussion.
Recent ONCSQ News
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 07:30:19 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM